Terms: = Colorectal cancer AND MAF, MGC71685, 4094, ENSG00000178573 AND Treatment
23 results:
1. Circulating tumour DNA at baseline for individualised prognostication in patients with chemotherapy-naïve metastatic colorectal cancer. An AGEO prospective study.
Bachet JB; Laurent-Puig P; Meurisse A; Bouché O; Mas L; Taly V; Cohen R; Gornet JM; Artru P; Louafi S; Thirot-Bidault A; Baumgaertner I; Coriat R; Tougeron D; Lecomte T; Mary F; Aparicio T; Marthey L; Blons H; Vernerey D; Taieb J
Eur J Cancer; 2023 Aug; 189():112934. PubMed ID: 37390800
[TBL] [Abstract] [Full Text] [Related]
2. Evaluation of
Lastraioli E; Bettiol A; Iorio J; Limatola E; Checcacci D; Parisi E; Bianchi C; Arcangeli A; Iannopollo M; Di Costanzo F; Di Lieto M
Cells; 2023 May; 12(11):. PubMed ID: 37296579
[TBL] [Abstract] [Full Text] [Related]
3. Genomic Landscape of Advanced Solid Tumors in Circulating Tumor DNA and Correlation With Tissue Sequencing: A Single Institution's Experience.
Gerratana L; Movarek M; Wehbe F; Katam N; Mahalingam D; Donahue J; Shah A; Chae YK; Mulcahy M; Tsarwhas D; Villaflor V; Kalyan A; Hussein M; Patel J; Chandra S; Platanias LC; Gradishar W; Cristofanilli M; Behdad A
JCO Precis Oncol; 2022 Jun; 6():e2100289. PubMed ID: 35772051
[TBL] [Abstract] [Full Text] [Related]
4. Encorafenib plus cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: real-life data from an Italian multicenter experience.
Boccaccino A; Borelli B; Intini R; Antista M; Bensi M; Rossini D; Passardi A; Tamberi S; Giampieri R; Antonuzzo L; Noto L; Roviello G; Zichi C; Salati M; Puccini A; Noto C; Parisi A; Rihawi K; Persano M; Crespi V; Libertini M; Giordano M; Moretto R; Lonardi S; Cremolini C
ESMO Open; 2022 Jun; 7(3):100506. PubMed ID: 35696748
[TBL] [Abstract] [Full Text] [Related]
5. Acoustic Array Biochip Combined with Allele-Specific PCR for Multiple cancer Mutation Analysis in Tissue and Liquid Biopsy.
Naoumi N; Michaelidou K; Papadakis G; Simaiaki AE; Fernández R; Calero M; Arnau A; Tsortos A; Agelaki S; Gizeli E
ACS Sens; 2022 Feb; 7(2):495-503. PubMed ID: 35073481
[TBL] [Abstract] [Full Text] [Related]
6. Training with Small Medical Data: Robust Bayesian Neural Networks for Colon cancer Overall Survival Prediction.
Hsu TC; Lin C
Annu Int Conf IEEE Eng Med Biol Soc; 2021 Nov; 2021():2030-2033. PubMed ID: 34891686
[TBL] [Abstract] [Full Text] [Related]
7. REMARRY and PURSUIT trials: liquid biopsy-guided rechallenge with anti-epidermal growth factor receptor (EGFR) therapy with panitumumab plus irinotecan for patients with plasma RAS wild-type metastatic colorectal cancer.
Nakajima H; Kotani D; Bando H; Kato T; Oki E; Shinozaki E; Sunakawa Y; Yamazaki K; Yuki S; Nakamura Y; Yamanaka T; Yoshino T; Ohta T; Taniguchi H; Kagawa Y
BMC Cancer; 2021 Jun; 21(1):674. PubMed ID: 34098908
[TBL] [Abstract] [Full Text] [Related]
8. Detection of tumor-derived cell-free DNA from colorectal cancer peritoneal metastases in plasma and peritoneal fluid.
Van't Erve I; Rovers KP; Constantinides A; Bolhuis K; Wassenaar EC; Lurvink RJ; Huysentruyt CJ; Snaebjornsson P; Boerma D; van den Broek D; Buffart TE; Lahaye MJ; Aalbers AG; Kok NF; Meijer GA; Punt CJ; Kranenburg O; de Hingh IH; Fijneman RJ
J Pathol Clin Res; 2021 May; 7(3):203-208. PubMed ID: 33635598
[TBL] [Abstract] [Full Text] [Related]
9. Detection of KRAS mutations in liquid biopsies from metastatic colorectal cancer patients using droplet digital PCR, Idylla, and next generation sequencing.
Holm M; Andersson E; Osterlund E; Ovissi A; Soveri LM; Anttonen AK; Kytölä S; Aittomäki K; Osterlund P; Ristimäki A
PLoS One; 2020; 15(11):e0239819. PubMed ID: 33237900
[TBL] [Abstract] [Full Text] [Related]
10. Peritoneal Cell-Free Tumor DNA as Biomarker for Peritoneal Surface Malignancies.
Leick KM; Kazarian AG; Rajput M; Tomanek-Chalkley A; Miller A; Shrader HR; McCarthy A; Coleman KL; Kasi PM; Chan CHF
Ann Surg Oncol; 2020 Dec; 27(13):5065-5071. PubMed ID: 32648179
[TBL] [Abstract] [Full Text] [Related]
11. Disease Monitoring Using Post-induction Circulating Tumor DNA Analysis Following First-Line Therapy in Patients with Metastatic colorectal cancer.
Max Ma X; Bendell JC; Hurwitz HI; Ju C; Lee JJ; Lovejoy A; Mancao C; Nicholas A; Price R; Sommer N; Tikoo N; Yao L; Yaung SJ; Palma JF
Clin Cancer Res; 2020 Aug; 26(15):4010-4017. PubMed ID: 32220893
[TBL] [Abstract] [Full Text] [Related]
12. Prediction of new targets and mechanisms for quercetin in the treatment of pancreatic cancer, colon cancer, and rectal cancer.
Pang B; Xu X; Lu Y; Jin H; Yang R; Jiang C; Shao D; Liu Y; Shi J
Food Funct; 2019 Sep; 10(9):5339-5349. PubMed ID: 31393490
[TBL] [Abstract] [Full Text] [Related]
13. Impact of circulating tumor DNA mutant allele fraction on prognosis in RAS-mutant metastatic colorectal cancer.
Elez E; Chianese C; Sanz-García E; Martinelli E; Noguerido A; Mancuso FM; Caratù G; Matito J; Grasselli J; Cardone C; Esposito Abate R; Martini G; Santos C; Macarulla T; Argilés G; Capdevila J; Garcia A; Mulet N; Maiello E; Normanno N; Jones F; Tabernero J; Ciardello F; Salazar R; Vivancos A
Mol Oncol; 2019 Sep; 13(9):1827-1835. PubMed ID: 31322322
[TBL] [Abstract] [Full Text] [Related]
14. Interleukin-17A polymorphisms predict the response and development of tolerance to FOLFOX chemotherapy in colorectal cancer treatment.
Bedoui S; Dallel M; Barbirou M; Stayoussef M; Mokrani A; Mezlini A; Bouhaouala B; Almawi WY; Yacoubi-Loueslati B
Cancer Gene Ther; 2020 May; 27(5):311-318. PubMed ID: 31138901
[TBL] [Abstract] [Full Text] [Related]
15. Association of interleukin-17A polymorphisms with the risk of colorectal cancer: A case-control study.
Bedoui SA; Barbirou M; Stayoussef M; Dallel M; Mokrani A; Makni L; Mezlini A; Bouhaouala B; Yacoubi-Loueslati B; Almawi WY
Cytokine; 2018 Oct; 110():18-23. PubMed ID: 29689450
[TBL] [Abstract] [Full Text] [Related]
16. Serial profiling of circulating tumor DNA for optimization of anti-VEGF chemotherapy in metastatic colorectal cancer patients.
Yamauchi M; Urabe Y; Ono A; Miki D; Ochi H; Chayama K
Int J Cancer; 2018 Apr; 142(7):1418-1426. PubMed ID: 29134647
[TBL] [Abstract] [Full Text] [Related]
17. Optimization of
Santos C; Azuara D; Garcia-Carbonero R; Alfonso PG; Carrato A; Elez ME; Gomez A; Losa F; Montagut C; Massuti B; Navarro V; Varela M; Lopez-Doriga A; Moreno V; Valladares M; Manzano JL; Vieitez JM; Aranda E; Sanjuan X; Tabernero J; Capella G; Salazar R
Mol Cancer Ther; 2017 Sep; 16(9):1999-2007. PubMed ID: 28626084
[TBL] [Abstract] [Full Text] [Related]
18. SUMOylated mafB promotes colorectal cancer tumorigenesis.
Yang LS; Zhang XJ; Xie YY; Sun XJ; Zhao R; Huang QH
Oncotarget; 2016 Dec; 7(50):83488-83501. PubMed ID: 27829226
[TBL] [Abstract] [Full Text] [Related]
19. Mucinous adenocarcinoma associated with a chronic perianal fistula - a review of cases from a single institution.
Koyama F; Nakagawa T; Nakamura S; Ueda T; Nishigori N; Inoue T; Kawasaki K; Obara S; Nakamoto T; Uchimoto K; Fujii H; Kido A; Tanaka Y; Yoshida K; Fujimoto K; Kuwahara M; Nakajima Y
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1866-8. PubMed ID: 25731357
[TBL] [Abstract] [Full Text] [Related]
20. Intersphincteric resection for very low rectal cancer: a systematic review.
Akagi Y; Kinugasa T; Shirouzu K
Surg Today; 2013 Aug; 43(8):838-47. PubMed ID: 23139048
[TBL] [Abstract] [Full Text] [Related]
[Next]
